Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma
PURPOSE Cholangiocarcinoma (CCA) remains a disease with poor prognosis and limited therapeutic options. Identification of driver genetic alterations may lead to the discovery of more effective targeted therapies. CCAs harboring FGFR2 fusions have recently demonstrated promising responses to FGFR inh...
Main Authors: | Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Vikneswari Rajasegaran, Tse Hui Lim, Kiat Hon Lim, Su Pin Choo, Simona Dima, Irinel Popescu, Dan G. Duda, Veerapol Kukongviriyapan, Narong Khuntikeo, Chawalit Pairojkul, Steven G. Rozen, Patrick Tan, Bin Tean Teh |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2020-11-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.20.00030 |
Similar Items
-
Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand
by: Sunitta Saensa-ard, et al.
Published: (2017-11-01) -
Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
by: Sarinya Kongpetch, et al.
Published: (2012-01-01) -
Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
by: Preawwalee Wintachai, et al.
Published: (2021-05-01) -
Liver fluke induces cholangiocarcinoma.
by: Banchob Sripa, et al.
Published: (2007-07-01) -
Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma
by: Supharada Tessiri, et al.
Published: (2022-01-01)